Developing an analytical method by HPLC for simultaneous quantification of methylene blue and metformin applied to in vitro skin permeation and retention studies-Reference-Cited by-同舟云学术

Developing an analytical method by HPLC for simultaneous quantification of methylene blue and metformin applied to in vitro skin permeation and retention studies

Published:2021-03-23 Issue:8 Volume:35 Page:
ISSN:0269-3879
Container-title:Biomedical Chromatography
language:en
Short-container-title:Biomedical Chromatography

Author:

Carvalho Matos Lisa¹,Calixto Leandro Augusto¹,Junqueira Garcia Maria Teresa¹^ORCID

Affiliation:

1. Institute of Environmental, Chemical and Pharmaceutical Sciences, Department of Pharmaceutical Sciences Federal University of São Paulo (Unifesp) Diadema São Paulo Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Wiley

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bmc.5112

Reference49 articles.

1. Anvisa. (2012).Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada—RDC no. 27 de 17 de maio de 2012. Dispõe sobre os requisitos mínimos para a validação de métodos bioanalíticos empregados em estudos com fins de registro e pós‐registro de medicamentos. Diário Oficial Da União no. 98 de 22 de Maio de 2012.http://antigo.anvisa.gov.br/documents/10181/3855414/RDC_27_2012_.pdf/6bb828cc-879a-418b-bdbd-f104c9eb598a

2. Anvisa. (2017a).Agência Nacional de Vigilância Sanitária. Guia para tratamento estatístico da validação analítica—Guia no. 10 de 30 de agosto de 2017. Agência Nacional de Vigilância Sanitária 1 1–19.http://antigo.anvisa.gov.br/documents/10181/2721567/(1)Guia+10+v1+Tratamento+estatistico+validacao+analitica.pdf/85b0e965-d72f-4b7c-bd2e-17de13af1976

3. Anvisa. (2017b).Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada—RDC no. 166 de 24 de julho de 2017. Dispõe sobre a validação de métodos analíticos e dá outras providências. Diário Oficial Da União no. 141 de 25 de Julho de 2017 87–90.https://www.in.gov.br/materia/‐/asset_publisher/Kujrw0TZC2Mb/content/id/19194581/do1‐2017‐07‐25‐resolucao‐rdc‐n‐166‐de‐24‐de‐julho‐de‐2017‐19194412

4. Metformin in dermatology: an overview

5. Factors influencing tumor response to photodynamic therapy sensitized by intratumor administration of methylene blue

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Patch/Film for Drug Delivery—Current Status and Future Prospects;Biopolymers;2024-09-04

2. Reverse phase, ion exchange, HILIC and mix-mode chromatography for the determination of metformin and evogliptin in human plasma and pharmaceutical formulations;Talanta Open;2024-08

3. Green synthesized Ag/rGO embedded flexible cotton SERS substrate for detection of methylene blue;2023-03-30

4. Monoolein-based nanodispersions for cutaneous co-delivery of methylene blue and metformin: Thermal and structural characterization and effects on the cutaneous barrier, skin penetration and cytotoxicity;International Journal of Pharmaceutics;2023-02